Provided by Tiger Fintech (Singapore) Pte. Ltd.

Prelude Therapeutics Inc

0.8413
-0.0045-0.53%
Post-market: 0.8343-0.0070-0.83%19:36 EDT
Volume:37.84K
Turnover:32.26K
Market Cap:47.50M
PE:-0.50
High:0.8883
Open:0.8700
Low:0.8260
Close:0.8458
Loading ...

Prelude Therapeutics Advances Cancer Treatment with PRT7732 Study

TIPRANKS
·
25 Jul

Prelude Therapeutics’ PRT7732 Study: A Potential Game-Changer for SMARCA4 Mutations

TIPRANKS
·
12 Jul

Prelude Therapeutics Advances Cancer Treatment with New Phase 2 Study

TIPRANKS
·
27 Jun

Prelude Therapeutics Appoints Paul Scherer as Director

TIPRANKS
·
14 Jun

Prelude Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
14 Jun

Prelude Therapeutics Inc. to Participate in Jefferies and Goldman Sachs Global Healthcare Conferences

Reuters
·
02 Jun

Prelude Therapeutics (PRLD) Receives a Sell from Barclays

TIPRANKS
·
07 May

Prelude Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

BRIEF-Prelude Therapeutics Q1 EPS USD -0.42

Reuters
·
07 May

Prelude Therapeutics Inc expected to post a loss of 47 cents a share - Earnings Preview

Reuters
·
02 May

Prelude Therapeutics to Participate in Citizens Life Sciences Conference in New York

Reuters
·
01 May

Prelude Announces Presentations at 2025 AACR Annual Meeting

GlobeNewswire
·
26 Apr

Prelude Therapeutics (PRLD) Upgraded to Buy: Here's What You Should Know

Zacks
·
11 Apr

Prelude Therapeutics Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
08 Apr

3 Promising Penny Stocks With Market Caps Up To $300M

Simply Wall St.
·
01 Apr

Prelude Therapeutics Founder Acquires 28% More Stock

Simply Wall St.
·
29 Mar

Prelude Therapeutics CEO Makes Bold Stock Purchase!

TIPRANKS
·
19 Mar

Prelude Therapeutics Reports 2024 Financial Results

TIPRANKS
·
11 Mar

Prelude Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
11 Mar

Prelude Therapeutics FY Sales $7.000M Beat $2.000M Estimate

Benzinga
·
10 Mar